Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s): CRDL

Healthcare

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.

TSX:CRDL - Post by User

Cardiol Therapeutics Inc

Bullboard Posts

Post by NewFanCBDon Jul 05, 2020 11:10pm

210 Views

Post# 31226991

Cardiol & Covid 19 = Great days ahead

We are about to see a resurgence in interest in CRDL. Covid 19 and a CBD response is going to be a big deal with very good results. This will create a new interest in the company when this gets rolled out. This week we move upwards. Huge potential here. Ignore the shorts, they will disappear soon!!!!

Bullboard Posts

Pro Women’s Hockey League comes to NHL 25 in December